Inventurus Knowledge Solutions Limited (the “Company”) announced that its wholly-owned subsidiary, Inventurus Knowledge Solutions, Inc. (“IKS Inc.”), has entered into a Stock Purchase Agreement (“SPA”). Under this agreement, IKS Inc. will sell certain Series A-1 Preferred Shares of Abridge Al Inc. to Alpha Square Group Fund IV, LP for an aggregate consideration of USD 10,000,175/-. This transaction represents a partial divestment by the subsidiary.
IKS Health Subsidiary Divests Stake in Abridge AI
Inventurus Knowledge Solutions Limited has disclosed that its wholly-owned subsidiary, Inventurus Knowledge Solutions, Inc. (“IKS Inc.”), has finalized a Stock Purchase Agreement (“SPA”) for the sale of its investment in Abridge AI Inc. The agreement, dated August 05, 2026, details the sale of Series A-1 Preferred Shares held by IKS Inc. in Abridge AI Inc. to Alpha Square Group Fund IV, LP, identified as the “Purchaser” in the transaction.
Transaction Details
The primary purpose of this agreement is the monetization and partial divestment of the Series A-1 Preferred Shares previously held by IKS Inc. The aggregate consideration for this sale is stated to be USD 10,000,175/-. This transaction involves the sale of 54,055 Series A-1 Preferred Shares.
Parties Involved
The parties involved in the Stock Purchase Agreement are:
- Seller: Inventurus Knowledge Solutions, Inc. (a wholly-owned subsidiary of Inventurus Knowledge Solutions Limited)
- Purchaser: Alpha Square Group Fund IV, LP
- Confirming Party: Abridge AI Inc.
The company has confirmed that the parties involved in this SPA are not related to the promoter, promoter group, or group companies of Inventurus Knowledge Solutions Limited. Furthermore, the transaction is not considered a related party transaction, and it has been conducted at an arms-length basis.
There are no specific disclosures related to shareholding, loan agreements, or termination/amendment details applicable to this particular transaction.
Source: BSE
